Ginkgo Bioworks Reports First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/27/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
Ginkgo Bioworks (DNA) Q1 Revenues Beat; Guides Higher
May 16, 2022 4:02 PM EDTGinkgo Bioworks (NYSE: DNA) reported Q1 revenue $168 million versus the consensus estimate of $105.68 million.
GUIDANCE:
Ginkgo Bioworks sees FY2022 revenue of $375-390 million, versus the consensus of $333 million.
For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.
... More